Treatment of hypermyoglobinemia after CRS plus HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study

被引:7
|
作者
Liu, Gang [1 ]
Ji, Zhong-He [1 ]
Yu, Yang [1 ]
Li, Xin-Bao [1 ]
Zhang, Yan-Bin [1 ]
Peng, Kai-Wen [1 ]
Li, Yan [1 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Peritoneal Canc Surg, 10 Tieyi Rd,Yangfangdian St, Beijing 100038, Peoples R China
关键词
cytoreductive surgery; hypermyoglobinemia; hyperthermic intraperitoneal chemotherapy; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; EPITHELIAL OVARIAN-CANCER; ACUTE KIDNEY INJURY; CYTOREDUCTIVE SURGERY; PSEUDOMYXOMA PERITONEI; COLORECTAL-CANCER; CHINESE CENTER; MYOGLOBIN; TRIAL;
D O I
10.1097/MD.0000000000008573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This retrospective comparative study aims to explore the time courses of serum myoglobin (Mb) changes, and summarize our experience in treating patients with hypermyoglobinemia after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).This study covered 60 patients with peritoneal carcinomatosis treated with CRS + HIPEC as the study group, and another 25 cancer patients treated with conventional extensive surgery without HIPEC as the control group from February to October 2016. In the study group, patients with postoperative hypermyoglobinemia were on a comprehensive treatment regimen consisting intravenous injection of sodium bicarbonate solution according to the Mb level. In the control group, patients were recorded and treated with the same regimen except for special sodium bicarbonate solution. The preoperative and postoperative serum Mb, blood urine nitrogen (BUN), and creatinine (Cr) levels were evaluated.There were no significantly difference between the 2 groups in serum Mb, BUN, and Cr levels before surgery. Postoperative serum Mb levels were elevated in both groups and significantly higher on postoperative 0 to 2 days (P<.05) in the study group than the control group. The peak value of serum Mb levels (426.65108.386 g/L) occurred on the surgery day. The serum Mb change rate was much bigger in the study group than the control group. Serum BUN levels in both groups revealed a slow increase during the early postoperative period and were significantly lower in the study group than the control group on days 1 and 2. The serum Cr levels were similar and stable between the 2 groups after surgery. The serum Cr change rates changed synchronously with same tendency in both groups, and on postoperative day 1 the increase rate was bigger in the control group than the study group.Hypermyoglobinemia is a common and prominent lab abnormality after CRS + HIPEC, and serum Mb levels could be an early and sensitive indicator for dramatic disturbances in the internal milieu after CRS + HIPEC. Adequate treatment with sodium bicarbonate could accelerate the reduction in serum Mb levels and reduce the risk for major organ damages.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC)
    Mary Garland-Kledzik
    Abhineet Uppal
    Yalda B. Naeini
    Stacey Stern
    Richard Erali
    Anthony J. Scholer
    Adam M. Khader
    Juan A. Santamaria-Barria
    Kathleen Cummins-Perry
    Yi Zhou
    Konstantinos I. Votanopoulos
    Perry Shen
    Edward A. Levine
    Anton J. Bilchik
    Journal of Gastrointestinal Surgery, 2021, 25 : 233 - 240
  • [42] Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study
    Dietz, Michelle V.
    Ziekman, Merijn J.
    van Kooten, Job P.
    Brandt-Kerkhof, Alexandra R. M.
    van Meerten, Esther
    Verhoef, Cornelis
    Madsen, Eva V. E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2048 - 2056
  • [43] Morbimortality after 1321 consecutive CRS plus HIPEC procedures: seeking excellence in surgery for peritoneal surface malignancy
    Bernado, Maria Isabel Ramos
    Mana, Oriol Crusellas
    Martin-Baranera, Montserrat
    Sanchez, Pedro Barrios
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (10): : 2911 - 2921
  • [44] Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC)
    Garland-Kledzik, Mary
    Uppal, Abhineet
    Naeini, Yalda B.
    Stern, Stacey
    Erali, Richard
    Scholer, Anthony J.
    Khader, Adam M.
    Santamaria-Barria, Juan A.
    Cummins-Perry, Kathleen
    Zhou, Yi
    Votanopoulos, Konstantinos, I
    Shen, Perry
    Levine, Edward A.
    Bilchik, Anton J.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (01) : 233 - 240
  • [45] Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study
    Michelle V. Dietz
    Merijn J. Ziekman
    Job P. van Kooten
    Alexandra R. M. Brandt-Kerkhof
    Esther van Meerten
    Cornelis Verhoef
    Eva V. E. Madsen
    Annals of Surgical Oncology, 2023, 30 : 2048 - 2056
  • [46] Different bidirectional HIPEC regimens after CRS in patients with peritoneal matastasis from colorectal cancer
    Glockzin, G.
    Gerken, M.
    Lang, S. A.
    Piso, P.
    Schlitt, H. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 46 - 46
  • [47] DOUBLE ARM STUDY OF PERFORMING BOWEL ANASTOMOSIS AFTER OR BEFORE HIPEC IN PATIENTS UNDERGOING CRS plus HIPEC FOR ADVANCED EPITHELIAL OVARIAN CANCER
    Somashekar, S.
    Ashwin, K.
    Ramya, Y.
    Zaveri, S.
    Ahuja, V.
    Kumar, C. Rohit
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A149 - A149
  • [48] ENDOSCOPIC GASTROENTEROSTOMY VERSUS SURGICAL GASTROJEJUNOSTOMY FOR THE TREATMENT OF GASTRIC OUTLET OBSTRUCTION IN PATIENTS WITH PERITONEAL CARCINOMATOSIS: A RETROSPECTIVE COMPARATIVE STUDY
    Bondi, Gayatri
    Bazarbashi, Ahmad Najdat
    Abbas, Ali M.
    Hathorn, Kelly
    Thompson, Christopher C.
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB303 - AB303
  • [49] Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters
    Geert A. Simkens
    Thijs R. van Oudheusden
    Hidde J. Braam
    Misha D. Luyer
    Marinus J. Wiezer
    Bert van Ramshorst
    Simon W. Nienhuijs
    Ignace H. de Hingh
    Annals of Surgical Oncology, 2016, 23 : 99 - 105
  • [50] Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters
    Simkens, Geert A.
    van Oudheusden, Thijs R.
    Braam, Hidde J.
    Luyer, Misha D.
    Wiezer, Marinus J.
    van Ramshorst, Bert
    Nienhuijs, Simon W.
    de Hingh, Ignace H.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (01) : 99 - 105